| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 14,619 | 12,628 | 15,393 | 22,375 | | Cost of Revenue | 9,854 | 9,127 | 10,747 | 14,955 | | | Gross Profit | 4,765 | 3,501 | 4,646 | 7,420 | | | Operating Expenses | | Research Development | 491 | 419 | 804 | 347 | | Selling General and Administrative | 6,105 | 6,315 | 5,602 | 5,179 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,831) | (3,233) | (1,760) | 1,894 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 75 | 123 | 169 | 325 | | Earnings Before Interest And Taxes | (1,756) | (3,110) | (1,591) | 2,219 | | Interest Expense | 74 | 56 | 26 | 33 | | Income Before Tax | (1,830) | (3,166) | (1,617) | 2,186 | | Income Tax Expense | (431) | (393) | (487) | 1,032 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,399) | (2,773) | (1,130) | 1,154 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,399) | (2,773) | (1,130) | 1,154 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,399) | ($2,773) | ($1,130) | $1,154 |
|
0.51% Nasdaq 
Income Statement
